Condition: Leiomyosarcoma Uterus · Sponsor: UNICANCER
Addition of postoperative chemotherapy to prevent or delay recurrence in patients newly diagnosed with localized uterine leiomyosarcoma and who have undergone complete tumor surgery.
This description comes directly from the study's public registry record.
Amel MEKALICHE, MS · +33 761947045 · a-mekaliche@unicancer.fr
Always discuss trial participation with your own doctor first.
| Institut de Cancerologie de L'Ouest (Ico) | Angers, France | Not Yet Recruiting |
| Hopital Jean Minjoz | Besançon, France | Not Yet Recruiting |
| Institut Bergonie | Bordeaux, France | Not Yet Recruiting |
| Centre Francois Baclesse | Caen, France | Not Yet Recruiting |
| Centre Jean Perrin | Clermont-Ferrand, France | Not Yet Recruiting |
| Centre Georges Francois Leclerc | Dijon, France | Not Yet Recruiting |
| Chu Limoges | Limoges, France | Not Yet Recruiting |
| Centre Léon Berard | Lyon, France | Not Yet Recruiting |
| Institut Paoli Calmettes | Marseille, France | Not Yet Recruiting |
| La Timone University Hospital | Marseille, France | Recruiting |
| Centre Antoine Lacassagne | Nice, France | Not Yet Recruiting |
| Hopital Saint Louis | Paris, France | Not Yet Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06524583